E&C Committee approves bill requiring companies to justify drug price increases

The House Energy & Commerce Committee approved by voice vote legislation that would require drug manufacturers to provide justification for pending drug price increases.

H.R. 2296,

Read the full 253 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE